Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Himanshu Upadhyaya

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|April 5, 2002
Adderall and seizuresStephanie Thomas, Himanshu Upadhyaya
Journal of the American Academy of Child and Adolescent Psychiatry|August 23, 2005
A practical clinical approach to the treatment of nicotine dependence in adolescentsHimanshu Upadhyaya, Deborah Deas, Kathleen Brady
The Lancet. Infectious Diseases|September 29, 2022
Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemicRussell M Nichols, Carmen Deveau, Himanshu Upadhyaya
Journal of the American Academy of Child and Adolescent Psychiatry|August 24, 2006
Pharmacological management of a youth with ADHD, marijuana use, and mood symptomsChristopher J Kratochvil, Timothy E Wilens, Himanshu Upadhyaya
Journal of Attention Disorders|April 17, 2015
What Is a Clinically Relevant Improvement in Quality of Life in Adults With ADHD?Yoko Tanaka, Meryl Brod, Jeannine R Lane, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 22, 2005
Pharmacological management of new-onset bipolar disorderChristopher J Kratochvil, Melissa Delbello, Himanshu Upadhyaya, et al.
Journal of Attention Disorders|August 14, 2016
Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults With ADHD: Relationship to Maintenance of Response and Relapse Over the Subsequent 6 Months After TreatmentLenard A Adler, Mary Solanto, Rodrigo Escobar, et al.
Applied Health Economics and Health Policy|March 30, 2013
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparisonCarlos I Alatorre, Virginia Haynes, Douglas Faries, et al.
Journal of Psychopharmacology (Oxford, England)|July 19, 2014
Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: an integrated analysis of the complete database of multicenter placebo-controlled trialsPhilip Asherson, Chris Bushe, Keith Saylor, et al.
Neuropsychiatric Disease and Treatment|February 23, 2017
A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbiditiesDavid B Clemow, Chris Bushe, Michele Mancini, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of the American Academy of Child and Adolescent Psychiatry|April 5, 2002
Adderall and seizuresStephanie Thomas, Himanshu Upadhyaya
Journal of the American Academy of Child and Adolescent Psychiatry|August 23, 2005
A practical clinical approach to the treatment of nicotine dependence in adolescentsHimanshu Upadhyaya, Deborah Deas, Kathleen Brady
The Lancet. Infectious Diseases|September 29, 2022
Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemicRussell M Nichols, Carmen Deveau, Himanshu Upadhyaya
Journal of the American Academy of Child and Adolescent Psychiatry|August 24, 2006
Pharmacological management of a youth with ADHD, marijuana use, and mood symptomsChristopher J Kratochvil, Timothy E Wilens, Himanshu Upadhyaya
Journal of Attention Disorders|April 17, 2015
What Is a Clinically Relevant Improvement in Quality of Life in Adults With ADHD?Yoko Tanaka, Meryl Brod, Jeannine R Lane, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 22, 2005
Pharmacological management of new-onset bipolar disorderChristopher J Kratochvil, Melissa Delbello, Himanshu Upadhyaya, et al.
Journal of Attention Disorders|August 14, 2016
Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults With ADHD: Relationship to Maintenance of Response and Relapse Over the Subsequent 6 Months After TreatmentLenard A Adler, Mary Solanto, Rodrigo Escobar, et al.
Applied Health Economics and Health Policy|March 30, 2013
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparisonCarlos I Alatorre, Virginia Haynes, Douglas Faries, et al.
Journal of Psychopharmacology (Oxford, England)|July 19, 2014
Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: an integrated analysis of the complete database of multicenter placebo-controlled trialsPhilip Asherson, Chris Bushe, Keith Saylor, et al.
Neuropsychiatric Disease and Treatment|February 23, 2017
A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbiditiesDavid B Clemow, Chris Bushe, Michele Mancini, et al.
Pageof 3